Day: July 12, 2019

L.E.A.F. Pharmaceuticals LLC et sa filiale L.E.A.F. Rwanda Ltd concluent un accord avec un façonnier pour la fabrication du LEAF-1404

KIGALI, Rwanda et VALLEY FORGE, Pennsylvanie, 12 juillet 2019 /PRNewswire/ — L.E.A.F. Rwanda Ltd (« LEAF Rwanda ») a annoncé ce jour la signature d’un contrat avec un façonnier américain, par l’intermédiaire de sa société mère américaine, L.E.A.F. Pharmaceuticals LLC, pour la fabrication de son premier anticancéreux générique complexe, le LEAF-1404, selon les normes CGMP mondiales. Installé aux États-Unis, […]

L.E.A.F. Pharmaceuticals LLC and its Affiliate L.E.A.F. Rwanda Ltd Enter into an Agreement with a Contract Manufacturing Organization to Manufacture LEAF-1404

KIGALI, Rwanda and VALLEY FORGE, Pennsylvania, July 11, 2019 /PRNewswire/ — L.E.A.F. Rwanda Ltd  (“LEAF Rwanda”) announced today that it has signed a manufacturing agreement with a US Contract Manufacturing Organization (CMO), through its United States (US) parent company, L.E.A.F. Pharmaceuticals LLC, to manufacture its first complex generic anticancer medicine, LEAF-1404, under global current good manufacturing […]